DeepMed Research

Medical University of Vienna

🇦🇹Austria

Country: 🇦🇹Austria

Ownership: Private

Established: 1365-01-01

Employees: 1K

Market Cap: -

Website: http://www.meduniwien.ac.at

Clinical Trials

Possible Effects of Energy Drink Ingestion on Perceived Alcohol Intoxication

Not Applicable

Conditions: Perceived Alcohol Intoxication

Interventions: Drug: Placebo (without alcohol, caffeine, energy drink)
Drug: Comparator 1 (with alcohol; without caffeine and energy drink)
Drug: Comparator 2 (with alcohol and caffeine; without energy drink)
Drug: Comparator 3 (with alcohol and energy drink)

First Posted Date: 2011-05-09

Last Posted Date: 2011-05-09

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 52

Registration Number: NCT01350089

Locations: 🇦🇹
Medical University of Vienna, Deparment of pediatric and adolescent medicine, Vienna, Austria

The Effect of Stimulating Substances on Brain Activity of Preterm Infants

Conditions: Apneas of Prematurity

First Posted Date: 2011-04-29

Last Posted Date: 2015-11-01

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 60

Registration Number: NCT01344317

Locations: 🇦🇹
Medical University of Vienna, Department of Pediatrics and Adolescent Medicine, Neonatology, Vienna, Austria
🇦🇹
Medical University of Vienna, Vienna, Austria

Choroidal Thickness During Changes in Intraocular Pressure and Arterial Blood Pressure

Not Applicable

Terminated

Conditions: Healthy

Interventions: Drug: Phenylephrine
Drug: Sodium-Nitroprusside
Device: Suction Cup
Device: Goldmann applanation tonometer
Device: 1060nm Optical coherence tomography

First Posted Date: 2011-04-12

Last Posted Date: 2014-11-14

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 1

Registration Number: NCT01333891

Locations: 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

Acetylic Salicylic Acid for the Treatment of Chronic Obstructive Pulmonary Disease

Phase 2

Conditions: COPD

Interventions: Drug: Acetylsalicylic acid

First Posted Date: 2011-04-04

Last Posted Date: 2012-12-25

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 74

Registration Number: NCT01328145

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

B-type Natriuretic Peptide and Glucose Metabolism

Not Applicable

Completed

Conditions: Diabetes Mellitus
Cardiomyopathy

Interventions: Drug: human BNP-32

First Posted Date: 2011-03-29

Last Posted Date: 2011-03-29

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 10

Registration Number: NCT01324739

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Antibiotic Concentration in Internal Mammary Graft Preparation

Conditions: Coronary Heart Disease
Surgical Wound Infection

First Posted Date: 2011-03-29

Last Posted Date: 2011-03-29

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 12

Registration Number: NCT01324804

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis

Phase 3

Completed

Conditions: Plaque Psoriasis

Interventions: Drug: Fumaric acid esters
Device: Full Body UV Therapy System UV 7002 plus fumaric acid esters

First Posted Date: 2011-03-23

Last Posted Date: 2014-05-12

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 30

Registration Number: NCT01321164

Locations: 🇦🇹
Medical University of Vienna; Department of Dermatology, Vienna, Austria

Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

Phase 2

Completed

Conditions: HHT
Morbus Osler
Epistaxis

Interventions: Drug: NaCl
Drug: Bevacizumab

First Posted Date: 2011-03-14

Last Posted Date: 2013-08-12

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 15

Registration Number: NCT01314274

Locations: 🇦🇹
Universitätsklinik für HNO, Medizinische Univeristät Wien, Vienna, Austria

Target Site Pharmacokinetics of Doripenem After a Single Dose of 500mg in Healthy Volunteers Dori_MD_1

Phase 4

Completed

Conditions: Healthy

Interventions: Drug: doripenem

First Posted Date: 2011-03-09

Last Posted Date: 2011-04-01

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 6

Registration Number: NCT01311141

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Recto-Anal-Repair in the Treatment of Advanced Haemorrhoidal Disease

Completed

Conditions: Haemorrhoids

First Posted Date: 2011-02-23

Last Posted Date: 2011-02-23

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 200

Registration Number: NCT01301209

Locations: 🇦🇹
Dept. of Surgery, Medical University Vienna, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy